SPONSOR
AP Biosciences Inc.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Locally Advanced or Metastatic Solid TumorsNon Small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)Esophageal Squamous Cell Carcinoma (ESCC)Advanced Solid Tumor
NCT05473156 Phase 1, Phase 2
Recruiting
A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies
Locally Advanced or Metastatic Solid Tumors
NCT06669975 Phase 1, Phase 2
Recruiting
A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid Tumors
Advanced Solid Tumor
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology